The amount of TFPI-2 mRNA within the tumour was therefore considered to be significantly different to the amount in the noncancerous lung when the NTFPI-2 value was either >4 (i.e. increased) or <0.25 (i.e. decreased). The gene discussed is TFPI2; the disease is neoplasm.